GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
ATHERSYS INC (ATHX) [hlAlert]

Athersys, Inc., is a biopharmaceutical company engaged in the discovery and development of therapeutic products. Through the application of its technologies, the Company has established a pipeline of therapeutic product development programs in multiple disease areas. The Company?s current product development portfolio consists
of MultiStem, a patented and stem cell product that the Company is developing as a treatment for multiple disease indications, and that is being evaluated in two ongoing clinical trials. In addition, the Company are developing novel pharmaceuticals to treat indications such as obesity, certain cognitive and attention disorders, narcolepsy or other forms of excessive daytime sleepiness. In December 2008, the Company were granted authorization by the United States Food and Drug Administration (FDA), to initiate a third clinical trial, administering MultiStem for the treatment of ischemic stroke.
.
( Total: 7 Current Stock Recommendations )
ATHERSYS INC   (7)
Buy 100%
Related companies
China Biologic ...   (4)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Filter by Gains:   
  
Rating:
Buy ATHX
down 22.44 %

Rating:
Buy ATHX
down 22.44 %
ATHERSYS INC (ATHX) rated Buy with price target $10 by Maxim Group
Thursday,  Dec 19, 2013  3:25 PM ET

Rating:
Buy ATHX
down 22.44 %

Rating:
Buy ATHX
down 22.44 %
ATHERSYS INC (ATHX) rated Buy with price target $3 by Maxim Group
Thursday,  May 31, 2012  10:25 AM ET

Rating:
Buy ATHX
down 61.61 %

Rating:
Buy ATHX
down 61.61 %

Rating:
Buy ATHX
down 67.24 %

Rating:
Buy ATHX
down 49.77 %

Rating:
Buy ATHX
down 49.77 %

Rating:
Buy ATHX
down 57.77 %

Rating:
Buy ATHX
down 64.81 %

Rating:
Buy ATHX
down 64.92 %
ATHERSYS INC (ATHX) rated Outperform by Cowen & Co
Monday,  Jun 2, 2008  8:25 AM ET

Your Recent Stocks
SymbolLastChange
ATHX 2.27 up  99.12 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy